Details for New Drug Application (NDA): 010996
✉ Email this page to a colleague
NDA 010996 describes DARVON W/ ASA, which is a drug marketed by Xanodyne Pharm and is included in one NDA. Additional details are available on the DARVON W/ ASA profile page.
The generic ingredient in DARVON W/ ASA is aspirin; propoxyphene hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; propoxyphene hydrochloride profile page.
The generic ingredient in DARVON W/ ASA is aspirin; propoxyphene hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; propoxyphene hydrochloride profile page.
Summary for 010996
| Tradename: | DARVON W/ ASA |
| Applicant: | Xanodyne Pharm |
| Ingredient: | aspirin; propoxyphene hydrochloride |
| Patents: | 0 |
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 325MG;65MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 006
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 389MG;32.4MG;32MG | ||||
| Approval Date: | Mar 8, 1983 | TE: | RLD: | No | |||||
Profile for product number 007
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 389MG;32.4MG;65MG | ||||
| Approval Date: | Mar 8, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
